The US Department of Justice is delving into a mind-boggling stock market phenomenon. Imagine a company's value skyrocketing by a staggering 46,000% in a flash! But this isn't a fairy tale; it's the reality for a Hong Kong-based traditional medicine firm. The DOJ's interest? Potential market manipulation.
On October 31, 2025, the DOJ took action, issuing a subpoena to Regencell Bioscience Holdings Ltd. This move demands the company's records related to trading in its shares and various internal affairs. The subpoena, filed with the SEC, sheds light on the DOJ's scrutiny of the company's operations.
But here's where it gets intriguing: The surge in the company's stock price occurred despite a lack of sales. This raises questions about the market's behavior and the potential influence of external factors. Could this be a case of market manipulation or an organic surge?
The DOJ's probe aims to uncover any suspicious activities or irregularities. With such a dramatic rise in stock value, the investigation is a necessary step to ensure market integrity. And this is the part most investors will watch closely, as the outcome could significantly impact the company's future.
The investigation is ongoing, and the DOJ's findings will be pivotal. Stay tuned as this story unfolds, and feel free to share your thoughts: Is this a classic case of market manipulation, or is there more to the story? Your opinions are welcome in the comments below!
